SSSS Form 4: Executive now holds 198,269 SuRo Capital shares

Rhea-AI Filing Summary

SuRo Capital Corp. reported an equity grant to a senior executive. On 11/21/2025, an officer of SuRo Capital received 956 shares of restricted common stock at a price of $0 under the company’s Second Amended and Restated 2019 Equity Incentive Plan. These restricted shares vest in three equal installments, with one-third vesting on December 1, 2026, one-third on December 1, 2027, and the final third on December 1, 2028.

Following this grant, the reporting person beneficially owns 198,269 shares of SuRo Capital common stock, including other restricted shares granted on December 15, 2023, December 10, 2024, and May 16, 2025 that remain subject to vesting schedules. The reporting person serves as Chief Financial Officer, Chief Compliance Officer, Treasurer and Corporate Secretary.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Green Allison

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	956	$0.00	--

Holdings After Transaction: Common Stock — 198,269 shares (Direct)

Footnotes (1)

1. Restricted shares granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, which vest as follows: 1/3 vests on December 1, 2026, 1/3 vests on December 1, 2027, and 1/3 vests on December 1, 2028. This total includes restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan on December 15, 2023, December 10, 2024 and May 16, 2025, which are subject to certain vesting schedules.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Allison

(Last) (First) (Middle)

C/O SURO CAPITAL CORP.

640 FIFTH AVENUE, 12TH FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SURO CAPITAL CORP. [ SSSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/21/2025		A(1)		956	A	$0	198,269(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, which vest as follows: 1/3 vests on December 1, 2026, 1/3 vests on December 1, 2027, and 1/3 vests on December 1, 2028.

2. This total includes restricted shares granted under the SuRo Capital Corp. Amended and Restated 2019 Equity Incentive Plan on December 15, 2023, December 10, 2024 and May 16, 2025, which are subject to certain vesting schedules.

Remarks:

Chief Financial Officer, Chief Compliance Officer, Treasurer and Corporate Secretary

	/s/ Allison Green	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did SuRo Capital Corp. (SSSS) disclose in this Form 4?

The filing discloses a grant of 956 restricted shares of common stock to a company officer on 11/21/2025 under SuRo Capital’s equity incentive plan.

What are the vesting terms of the 956 restricted shares reported by SSSS?

The 956 restricted shares vest in three equal installments: 1/3 on December 1, 2026, 1/3 on December 1, 2027, and 1/3 on December 1, 2028.

How many SuRo Capital (SSSS) shares does the reporting person own after this transaction?

After the reported grant, the officer beneficially owns 198,269 shares of SuRo Capital common stock, including previously granted restricted shares that are still vesting.

Under which plan were the new restricted SSSS shares granted?

The 956 restricted shares were granted under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan.

What executive roles does the reporting person hold at SuRo Capital Corp. (SSSS)?

The reporting person serves as Chief Financial Officer, Chief Compliance Officer, Treasurer and Corporate Secretary of SuRo Capital Corp.

Are there earlier restricted share grants mentioned for the SSSS officer?

Yes. The total beneficial ownership includes restricted shares granted on December 15, 2023, December 10, 2024, and May 16, 2025, which are subject to vesting schedules.